NRAS and chronic myelomonocytic leukemia: In CMML, a high mutational burden, more than 3 mutated epigenetic regulators and the presence of NRAS mutations are associated with disease relapse [37], whereas survival is adversely affected by the presence of ASXL1 mutations [38].